- Journal of Pharmacopunture 2019 Study: A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC
- Front Pharmacol 2017 Abstract: Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer’s Disease
- Science Direct 2016 Article: Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease
- Nature 2016 Abstract: Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
- Semantic Scholar 2016 Study: Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease
- CNS Drugs 2015 Abstract: Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
ASCPT 2015 Abstract: Cannabinoids in late‐onset Alzheimer’s disease - Frontiers in Pharmacology 2014 Article: Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
- Journal of Neuroinflammation 2012 Abstract: Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
- Molecular Pharmacology 2011 Abstract: Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer’s Disease
- British Pharmacological Society 2009 Abstract: Alzheimer’s disease; taking the edge off with cannabinoids
- NCBI 2005 Abstract: Cannabinol delays symptom onset in SOD1
- JNeurosci 2005 Study: Prevention of Alzheimer’s Disease Pathology by Cannabinoids
- Science Direct 2004 Abstract: Role of the endocannabinoid system in Alzheimer’s disease: New perspectives
Alzheimer’s Disease
Alzheimer’s Disease
Last Update: June 14, 2023